SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sanofi India - Quaterly Results

23 Feb 2024 Evaluate
The Total revenue for the quarter ended December 2023 of  Rs. 6939.00 millions remain, more or less, the same.Profit saw a slight increase of 5.19%to Rs. 1377.00  millions from Rs. 1309.00 millions.Operating profit surged to 1994.00 millions from the corresponding previous quarter of 1869.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202312 202212 % Var
Sales 6939.00 6719.00 3.27 28511.00 27701.00 2.92 28511.00 27701.00 2.92
Other Income 120.00 200.00 -40.00 653.00 715.00 -8.67 653.00 715.00 -8.67
PBIDT 1994.00 1869.00 6.69 8693.00 7759.00 12.04 8693.00 7759.00 12.04
Interest 4.00 4.00 0.00 17.00 17.00 0.00 17.00 17.00 0.00
PBDT 1990.00 2004.00 -0.70 8854.00 9062.00 -2.30 8854.00 9062.00 -2.30
Depreciation 102.00 100.00 2.00 396.00 419.00 -5.49 396.00 419.00 -5.49
PBT 1888.00 1904.00 -0.84 8458.00 8643.00 -2.14 8458.00 8643.00 -2.14
TAX 511.00 595.00 -14.12 2426.00 2437.00 -0.45 2426.00 2437.00 -0.45
Deferred Tax 15.00 -35.00 -142.86 -7.00 -15.00 -53.33 -7.00 -15.00 -53.33
PAT 1377.00 1309.00 5.19 6032.00 6206.00 -2.80 6032.00 6206.00 -2.80
Equity 230.00 230.00 0.00 230.00 230.00 0.00 230.00 230.00 0.00
PBIDTM(%) 28.74 27.82 3.31 30.49 28.01 8.85 30.49 28.01 8.85

Sanofi India Share Price

3587.20 8.65 (0.24%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×